FreshLeaf’s industry reports provide detailed and up-to-date information on medical cannabis in Australia. We track product availability, price movements, new market entrants, doctor behaviour, patient preferences, regulatory changes and more. The reports are free to download and showcase our capability. Please contact us if you would like to discuss custom analysis to address your specific business requirements.
Latest Australian Medicinal Cannabis Market - H2 2021
Our Q1 2020 report includes our first ever historical price and patient dose analysis combining data from our previous publications to show long-term market trends.
Our Q3 2019 report is the most comprehensive review of the marketplace to date, the product of two-and-a-half years constantly and cumulatively tracking data.
Our analysis has revealed that over the past 12 months, there has been a significant increase in the number, and variety of legal products on offer to Australian patients.
FreshLeaf Analytics H2 2021
The H2 2021 report is FreshLeaf Analytics’ seventh market report on patients, products and pricing in the Australian medicinal cannabis market.
Key highlights include:
Market growth will exceed expectations in 2021 as active patient numbers surge towards 100,000
Revenue from product sales forecast at $230 million at year end
Product count continues to climb although the growth rate of new products is slowing
Average monthly spend continues its slow downward trend while average daily dose increases